You searched for Antibody candidate - Page 26 of 69

glioblastoma oncolytic virus transgene 2

News and Trends 20 Sep 2022

Collaboration to develop new glioblastoma combination therapy nets €1.06M

…by Amsterdam UMC and will help CimCure to study passive immunization. Additionally, Covalab will develop full-length and antibody fragments, to be used for CAR-T cells. This novel approach to antibody…

September 20, 2022 - 4 minutesmins - By Jim Cornall

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

…Aduro believes its drug candidate can be combined with immune checkpoint inhibitors to induce immunity. Hans van Eenennaam: Our lead antibody program, targeting the APRIL gene, a key driver in…

July 24, 2018 - 6 minutesmins - By Editorial Team

News and Trends 6 Apr 2020

UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients

…we can prevent or reduce deterioration in Covid-19 patients for which there are currently few treatments available.” Izana’s antibody therapy is a human monoclonal antibody targeting GM-CSF and is in…

April 6, 2020 - 2 minutesmins - By David Kirk

Interview 11 Sep 2017

Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech

…example, a bispecific antibody, we can do this in-house. We’ve been able to create two completely new next-generation antibody technology platforms, DuoBody and HexaBody for bispecific and immune effector function…

September 11, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 26 Aug 2016

Antibodyomes for faster Discovery of Biologicals, with Memo Therapeutics

…Armin W. Mäder Mission: Memo Therapeutics develops complete antibody repertoires (antibodyomes) of humans and animals, in order to have cost and time-effective molecular cloning, biobanking and expression screening. The result…

August 26, 2016 - 1 minutemin - By Joachim Eeckhout

News and Trends 6 Dec 2016

How is European Immuno-Oncology fighting Blood Cancer?

…also announced Phase I results for IPH4102, a humanized monoclonal antibody to treat cutaneous T-cell lymphomas (CTCL), a subtype of non-Hodgkin’s lymphoma. Argenx, in the Netherlands, has two antibody…

December 6, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Oct 2022

AbbVie acquires LifeArc portfolio company DJS Antibodies

AbbVie has acquired LifeArc’s portfolio company DJS Antibodies Limited, a privately-held UK-based biotechnology company dedicated to discovering and developing antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled…

October 20, 2022 - 3 minutesmins - By Jim Cornall

In Depth 3 Mar 2023

Let’s Take a Closer Look at 7 Autoimmune Diseases Biotechs are Fighting to Treat

…baseline. The Danish LEO Pharma also received approval from the European Medicines Agency (EMA) for its antibody Kyntheum (brodalumab). Following closely behind, for its antibody guselkumab, German biotech MorphoSys was…

March 3, 2023 - 8 minutesmins - By Alexander Burik

News and Trends 25 Mar 2025

AbbVie and Genmab: Can a legal battle break a billion-dollar bond?

…technology related to antibody-drug conjugates (ADCs). Genmab has rejected the claims and said it will defend itself, insisting the dispute will not impact its ongoing collaborations with AbbVie. But it’s…

March 25, 2025 - 5 minutesmins - By Jules Adam

Best in Biotech 19 Sep 2023

Five biotech companies taking Los Angeles by storm

…clinical candidate is vudalimab, which is currently in ongoing phase 2 clinical studies in metastatic castration-resistant prostate cancer and gynecologic tumors. The drug is a bispecific antibody that simultaneously targets…

September 19, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 22 Feb 2022

Fast Stroke Treatments in the Works with TargED’s €39M Series A

…Microlyse is a fusion protein drug combining an antibody fragment with a fragment of a clot-busting enzyme. The antibody part of the drug seeks out a protein target found in…

February 22, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 31 Aug 2022

Researchers identify possible target for type of sporadic ALS

…cells. When a synthetic antibody designed specifically to recognize HERV-K ENV was added as well to those neurons, the toxic effects were reduced. These findings together suggest that the improper…

August 31, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Collaboration to develop new glioblastoma combination therapy nets €1.06M

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients

Meet the CEO of Europe’s Largest & Most Fiercely Independent Biotech

Antibodyomes for faster Discovery of Biologicals, with Memo Therapeutics

How is European Immuno-Oncology fighting Blood Cancer?

AbbVie acquires LifeArc portfolio company DJS Antibodies

Let’s Take a Closer Look at 7 Autoimmune Diseases Biotechs are Fighting to Treat

AbbVie and Genmab: Can a legal battle break a billion-dollar bond?

Five biotech companies taking Los Angeles by storm

Fast Stroke Treatments in the Works with TargED’s €39M Series A

Researchers identify possible target for type of sporadic ALS

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!